Interferon therapy for acute hepatitis C viral infection - A review by meta-analysis

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 5, 1997, Pages 611-618

  Quin, J W ^a,b  

^a Cystic Fibrosis/Pulmon Res T   (Australia)

^b Director of Clinical Immunology and HIV Medicine Sexual Health   (Australia)

Author keywords

Acute hepatitis C viral infection; Interferon therapy; Meta analysis

Indexed keywords

ALPHA2B INTERFERON; BETA INTERFERON; INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ACUTE HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; META ANALYSIS; REVIEW; TREATMENT OUTCOME;

EID: 0030831796     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb00985.x     Document Type: Review

References (30)

1. Andrews R, Curran M, for the Communication Diseases Network Australia and New Zealand. Enhanced Surveillance for incident cases of hepatitis C in Australia 1995. Comm Dis Intell 1996; 20: 384-8.
2. Leader S. The public health challenge of hepatitis C. First Australian Conference on Hepatitis C. March, 1997, Sydney.
3. Crofts N, Aitken C. Hepatitis C in a cohort of Victorian injecting drug users. First Australian Conference on Hepatitis C, Sydney - abstracts. 1997; 32-3.
4. Sodeyama T, Kiyosawa K, Urushihara A et al. Transmission of hepatitis C virus through needlestick accidents in health care workers. Viral hepatitis and liver disease. 1994; 459-62.
5. Arai Y, Noda K, Enomoto V et al. A prospective study of hepatitis C virus infection after needlestick accidents. Liver 1996; 16: 331-4.
6. Kiyosawa K, Sodeyama T, Tanaku E et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991; 115: 367-9.
7. Mitsui T, Iwanok K, Masuko K et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16: 1109-14.
8. Healey CJ, Sabharwal NK, Daub J et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virusscreened intravenous immunoglobulin therapy. Gastroenterology 1996; 110: 1120-6.
9. Brink NS, Chopra R, Perrons CJ et al. Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virologie study. Br J Hepatology 1993; 83: 498-503.
10. Vogel W, Grazladei I, Umlauft F et al. High-dose interferon-α2b treatment prevents chronicity in acute hepatitis C. A pilot study. Di Dis Sci 1996; 41: 81S-85S.
11. Satori M, La Terra C, Agiretta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993; 25: 270-1.
12. Healy CJ, Smith DB, Walker JL et al. Acute hepatitis C infection after sexual exposure. Gut 1995; 36: 148-50.
13. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
14. Hoofnagle JH, Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-56.
15. Camma C, Almasio P, Craxi A. Interferon as treatment for acute hepatitis C. A meta-analysis. Di Dis Sci 1996; 41: 1248-55.
16. Viladomiu L, Genesca J, Esteban J et al. Interferon-α in acute post transfusion hepatitis C: a randomised controlled trial. Hepatology 1992; 15: 767-9.
17. Colombo M, Lampertico P, Rumi M. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non A, non B/type C hepatitis after transfusion.- Gut 1993; S141.
18. Tassopoulos NC, Koutelou MG, Papatheodoridis G et al. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993; S130-2.
19. Lampertico P, Rumi M, Romeo R et al. A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994; 19: 19-22.
20. Li XW. A report on therapy of interferon A-2b in patients with acute hepatitis. (Chinese) Chin J Int Med 1993; 32: 409-11.
21. Genesca J, Esteban JI, Quer J et al. Hepatitis C virus makers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. Gut 1993; S62-3.
22. Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ. A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994; 21: 831-6.
23. Palmovic DI, Kurelac I, Crnjakovic-Palmovic J. The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 1994; 22: 222-3.
24. Alberti A, Chemello L, Belussi F et al. Outcome of acute hepatitis C and role of alpha interferon therapy. Viral hepatitis and liver diseases. 1994; 604-6.
25. Omata M, Takano S. A randomised controlled trial of Interferon-β treatment of acute hepatitis C. Viral hepatitis and liver disease. 1994; 601-3.
26. Takano S, Satomura Y, Omata M and Japan acute hepatitis co-operative study groups. Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomised, controlled-dose study. Gastroenterology 1994; 107: 805-11.
27. Fukui S, Tohyama H, Iwabuchi S. Interferon therapy for acute hepatitis C; changes in serum makers associated with HCV and clinical effects. Jap J Clin Med 1994; 52: 1847-51.
28. DerSimonian R, Liard N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-88.
29. Petitti DB. Meta-analysis, decision analysis and costeffectiveness analysis: Methods for quantitative synthesis in medicine. Oxford: Oxford University Press, 1994; 90-114.
30. Serfaty L, Chazouilleres O, Pawlotsky J-M, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996; 110: 291-5.